 CAMBRIDGE, Mass., Nov. 23, 2020 GLOBE NEWSWIRE -- Codiak BioSciences, Inc. NASDAQ: CDAK, a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference. Details are as follows: 